ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells.

Alan M Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.